Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Clinical research challenges posed by difficult-to-treat depression
A. John Rush
, Harold A. Sackeim
,
Charles R. Conway
, Mark T. Bunker
, Steven D. Hollon
, Koen Demyttenaere
, Allan H. Young
, Scott T. Aaronson
, Maxine Dibué
, Michael E. Thase
, R. Hamish McAllister-Williams
Institute of Clinical and Translational Sciences (ICTS)
Division of Clinical Neuroscience and Behavioral Health Research
Research output
:
Contribution to journal
›
Review article
›
peer-review
79
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clinical research challenges posed by difficult-to-treat depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Remission
100%
Major Depression
100%
Clinical Management
100%
Intervention Research
100%
Therapy Effect
100%
Health Care
100%
Quality of Life
100%
Side Effect
100%
Patient Experience
100%
Keyphrases
Clinical Research
100%
Difficult-to-treat Depression
100%
Sustained Impact
33%
Major Depressive Disorder
16%
Clinical Management
16%
Clinical Intervention
16%
Evidence-based
16%
Reliable Assessments
16%
Treatment Outcome
16%
Therapeutic Effect
16%
Mental Health Care
16%
Patient Experience
16%
Heterogeneous Groups
16%
Clinical Trial Design
16%
Healthcare Resources
16%
Life Functioning
16%
Design Decisions
16%
Clinical Trial Methodology
16%
Causal Inference
16%
Sustained Remission
16%
Quality of Life Impact
16%
Intervention Research
16%
Treatment Selection
16%
Multiple Wells
16%
Clinically Meaningful Outcomes
16%
Daily Functioning
16%
Trial Methodology
16%
Focus of Attention
16%
Concomitant Treatment
16%
Symptomatic Change
16%
Clinical Subtyping
16%
Group Selection
16%
General Healthcare
16%
Mathematics
Causal Inference
100%
Healthcare
100%
Trial Design
100%
Control Group
100%
Generalizability
100%
Focus Attention
100%
Heterogeneous Group
100%
Psychology
Quality of Life
100%
Healthcare
100%
Causal Inference
100%
Major Depressive Disorder
100%
Major Depression
100%
Major Depressive Episode
100%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Research
100%
Clinical Trial
50%
Remission
50%
Major Depression
50%
Therapeutic Effect
50%
Clinical Trial Design
50%
Side Effect
50%
Neuroscience
Major Depressive Disorder
100%
Clinical Intervention
100%
Side Effect
100%
Quality of Life
100%